Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H16N5O13P3 |
Molecular Weight | 507.181 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]3O
InChI
InChIKey=ZKHQWZAMYRWXGA-KQYNXXCUSA-N
InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
Molecular Formula | C10H16N5O13P3 |
Molecular Weight | 507.181 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:45 UTC 2023
by
admin
on
Fri Dec 15 15:00:45 UTC 2023
|
Record UNII |
8L70Q75FXE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
73675-1
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
||
|
LOINC |
1721-0
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
||
|
LOINC |
10557-7
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
||
|
LOINC |
35135-3
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
||
|
LOINC |
46701-9
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
||
|
DSLD |
3264 (Number of products:65)
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ADENOSINE TRIPHOSPHATE
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
C209
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
DTXSID6022559
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
8L70Q75FXE
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
318
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | RxNorm | ||
|
56-65-5
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
m1413
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | Merck Index | ||
|
91
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
8L70Q75FXE
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
5957
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
100000092008
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
SUB12741MIG
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
15422
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
DB00171
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
200-283-2
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY | |||
|
D000255
Created by
admin on Fri Dec 15 15:00:45 UTC 2023 , Edited by admin on Fri Dec 15 15:00:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SUBSTRATE -> TARGET |
recAP has a dual mechanism of action via dephosphorylation of both lipopolysaccharides (LPS) and extracellular ATP.
|
||
|
TRANSPORTER -> SUBSTRATE |
Principal exporter of ATP, and
increased Panx1 expression and stimulation are correlated with an increase in ATP efflux.
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
DNP decreases the formation of high-energy phosphate bonds in mitochondria and at the same time stimulates systemic oxygen consumption. This dissociative effect is known as uncoupling of oxidative phosphorylation. Weak uncoupler.
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |